These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 26158773)
21. Hybrid Antigens Expressing Surface Loops of ZnuD From Qamsari MM; Rasooli I; Chaudhuri S; Astaneh SDA; Schryvers AB Front Immunol; 2020; 11():158. PubMed ID: 32117294 [No Abstract] [Full Text] [Related]
22. Evaluation of the Protective Efficacy of a Fused OmpK/Omp22 Protein Vaccine Candidate against Acinetobacter baumannii Infection in Mice. Guo SJ; Ren S; Xie YE Biomed Environ Sci; 2018 Feb; 31(2):155-158. PubMed ID: 29606195 [TBL] [Abstract][Full Text] [Related]
23. A new strain of Acinetobacter baumannii and characterization of its ghost as a candidate vaccine. Sheweita SA; Batah AM; Ghazy AA; Hussein A; Amara AA J Infect Public Health; 2019; 12(6):831-842. PubMed ID: 31230953 [TBL] [Abstract][Full Text] [Related]
24. In silico analysis of Acinetobacter baumannii phospholipase D as a subunit vaccine candidate. Hosseingholi EZ; Rasooli I; Gargari SL Acta Biotheor; 2014 Dec; 62(4):455-78. PubMed ID: 24957752 [TBL] [Abstract][Full Text] [Related]
25. Immunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumannii. Singh R; Capalash N; Sharma P Sci Rep; 2017 Sep; 7(1):12411. PubMed ID: 28963492 [TBL] [Abstract][Full Text] [Related]
26. A novel approach of virulome based reverse vaccinology for exploring and validating peptide-based vaccine candidates against the most troublesome nosocomial pathogen: Acinetobacter baumannii. Ahmad S; Azam SS J Mol Graph Model; 2018 Aug; 83():1-11. PubMed ID: 29753164 [TBL] [Abstract][Full Text] [Related]
30. Subtractive proteomics to identify novel drug targets and reverse vaccinology for the development of chimeric vaccine against Acinetobacter baumannii. Solanki V; Tiwari V Sci Rep; 2018 Jun; 8(1):9044. PubMed ID: 29899345 [TBL] [Abstract][Full Text] [Related]
31. New putative vaccine candidates against Acinetobacter baumannii using the reverse vaccinology method. Fereshteh S; Abdoli S; Shahcheraghi F; Ajdary S; Nazari M; Badmasti F Microb Pathog; 2020 Jun; 143():104114. PubMed ID: 32145321 [TBL] [Abstract][Full Text] [Related]
32. Vaccination induces rapid protection against bacterial pneumonia via training alveolar macrophage in mice. Gu H; Zeng X; Peng L; Xiang C; Zhou Y; Zhang X; Zhang J; Wang N; Guo G; Li Y; Liu K; Gu J; Zeng H; Zhuang Y; Li H; Zhang J; Zhang W; Zou Q; Shi Y Elife; 2021 Sep; 10():. PubMed ID: 34544549 [TBL] [Abstract][Full Text] [Related]
33. Immunogenic reactivity of recombinant PKF and AbOmpA proteins as serum resistance factors against sepsis of Acinetobacter baumannii. Bolourchi N; Shahcheraghi F; Shirazi AS; Janani A; Bahrami F; Badmasti F Microb Pathog; 2019 Jun; 131():9-14. PubMed ID: 30930220 [TBL] [Abstract][Full Text] [Related]
34. Protection against Acinetobacter baumannii infection via its functional deprivation of biofilm associated protein (Bap). Fattahian Y; Rasooli I; Mousavi Gargari SL; Rahbar MR; Darvish Alipour Astaneh S; Amani J Microb Pathog; 2011 Dec; 51(6):402-6. PubMed ID: 21946278 [TBL] [Abstract][Full Text] [Related]
35. A lethal pneumonia model of Acinetobacter baumannii: an investigation in immunocompetent mice. Zeng X; Gu H; Cheng Y; Jia KR; Liu D; Yuan Y; Chen ZF; Peng LS; Zou QM; Shi Y Clin Microbiol Infect; 2019 Apr; 25(4):516.e1-516.e4. PubMed ID: 30583061 [TBL] [Abstract][Full Text] [Related]
36. Designing Multi-Antigen Vaccines Against McConnell MJ; Martín-Galiano AJ Front Immunol; 2021; 12():666742. PubMed ID: 33936107 [TBL] [Abstract][Full Text] [Related]